Open Beta
MetriLume

US marketsCODX

SEC-sourced researchBeta

CODX

Co-Diagnostics, Inc.

Company comparison ↗

Data passport

CIK
0001692415
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 3,915,160.0000 USD; December 2025: 622,489.0000 USD3.9M USD0 USD0December 2024December 2025
CODX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20243,915,160.0000Mar 31, 2026
December 2025622,489.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025622,489.0000-46,895,936.0000-29,136,927.000024,742,585.00004,113,921.0000Mar 31, 2026
December 20243,915,160.0000-37,639,008.0000-29,155,045.000063,563,158.00009,688,001.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$622.49KDecember 2025Mar 31, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3.92MDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss-$46.9MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$29.14MDecember 2025Mar 31, 202610-K
Total assetsAssets$24.74MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$4.11MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗